Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Synthesis and anti-HIV activity of [d4U]-spacer-[HI-236] bifinctional HIV-1 reverse transcriptase inhibitors

Includes bibliographical references (leaves 182-190).

Saved in:
Bibliographic Details
Main Author: Muhanji, Clare Imbosa
Other Authors: Hunter, Roger
Format: Thesis
Language:English
Published: Department of Chemistry 2014
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613208694489088
access_status_str Open Access
author Muhanji, Clare Imbosa
author2 Hunter, Roger
author_browse Hunter, Roger
Muhanji, Clare Imbosa
author_facet Hunter, Roger
Muhanji, Clare Imbosa
author_sort Muhanji, Clare Imbosa
collection Thesis
description Includes bibliographical references (leaves 182-190).
format Thesis
id oai:open.uct.ac.za:11427/6346
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:32:29.432Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2014
publishDateRange 2014
publishDateSort 2014
publisher Department of Chemistry
publisherStr Department of Chemistry
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/6346 Synthesis and anti-HIV activity of [d4U]-spacer-[HI-236] bifinctional HIV-1 reverse transcriptase inhibitors Muhanji, Clare Imbosa Hunter, Roger Chemistry Includes bibliographical references (leaves 182-190). This thesis describes the design and synthesis of bifunctional drugs combining anucleoside (d4U) and non-nucleoside (HI-236) reverse transcriptase inhibitor linkedvia different spacers between C-5 of the NRTI and 0-1 of the NNRTI. Three targets were successfully synthesized in a divergent manner from uridine in 13steps for the butyne target and 19 steps for targets bearing PEG-propyne units usingSonogashira coupling as a key step. The most challenging step of the synthesisinvolved Boc deprotection and thiourea condensation in the final step, which sufferedfrom anomeric cleavage with loss of the sugar moiety. As a result, the target with athree-carbon propynyl spacer could not be accessed. Progress towards the synthesis of a bifunctional system bearing a saturated andmore flexible tether is highlighted in Chapter 4. The key reactions includedSonogashira coupling of iodo nucleosides, 2',3'-dideoxygenation of the vicinol diol,phenolic alkylation and condensation of amine with thiourea reagent. The synthesissurmounted several challenges, with chemoselective distinction of unsaturation vialate introduction of the d4U double bond using Corey-Winter methodology as thehighlight. 2014-08-13T14:27:31Z 2014-08-13T14:27:31Z 2006 Doctoral Thesis Doctoral PhD http://hdl.handle.net/11427/6346 eng application/pdf Department of Chemistry Faculty of Science University of Cape Town
spellingShingle Chemistry
Muhanji, Clare Imbosa
Synthesis and anti-HIV activity of [d4U]-spacer-[HI-236] bifinctional HIV-1 reverse transcriptase inhibitors
thesis_degree_str Doctoral
title Synthesis and anti-HIV activity of [d4U]-spacer-[HI-236] bifinctional HIV-1 reverse transcriptase inhibitors
title_full Synthesis and anti-HIV activity of [d4U]-spacer-[HI-236] bifinctional HIV-1 reverse transcriptase inhibitors
title_fullStr Synthesis and anti-HIV activity of [d4U]-spacer-[HI-236] bifinctional HIV-1 reverse transcriptase inhibitors
title_full_unstemmed Synthesis and anti-HIV activity of [d4U]-spacer-[HI-236] bifinctional HIV-1 reverse transcriptase inhibitors
title_short Synthesis and anti-HIV activity of [d4U]-spacer-[HI-236] bifinctional HIV-1 reverse transcriptase inhibitors
title_sort synthesis and anti hiv activity of d4u spacer hi 236 bifinctional hiv 1 reverse transcriptase inhibitors
topic Chemistry
url http://hdl.handle.net/11427/6346
work_keys_str_mv AT muhanjiclareimbosa synthesisandantihivactivityofd4uspacerhi236bifinctionalhiv1reversetranscriptaseinhibitors